1. Home
  2. MAGN vs MRVI Comparison

MAGN vs MRVI Comparison

Compare MAGN & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Magnera Corporation

MAGN

Magnera Corporation

HOLD

Current Price

$12.93

Market Cap

465.3M

ML Signal

HOLD

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$3.54

Market Cap

472.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAGN
MRVI
Founded
1864
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Paper
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
465.3M
472.8M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
MAGN
MRVI
Price
$12.93
$3.54
Analyst Decision
Buy
Buy
Analyst Count
1
7
Target Price
$19.00
$4.57
AVG Volume (30 Days)
442.3K
1.1M
Earning Date
01-01-0001
05-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.29
EPS
N/A
N/A
Revenue
N/A
$185,743,000.00
Revenue This Year
$4.09
N/A
Revenue Next Year
$2.34
$10.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.82
$1.67
52 Week High
$20.89
$4.11

Technical Indicators

Market Signals
Indicator
MAGN
MRVI
Relative Strength Index (RSI) 37.67 61.55
Support Level $12.56 $3.25
Resistance Level $15.14 $3.65
Average True Range (ATR) 0.56 0.15
MACD -0.12 0.07
Stochastic Oscillator 9.24 72.58

Price Performance

Historical Comparison
MAGN
MRVI

About MAGN Magnera Corporation

Magnera Corp is a supplier of a diverse portfolio of specialty materials comprised of organic and synthetic raw ingredients. The company markets its own products predominantly into stable, consumer-oriented end markets, including wipes, healthcare, adult incontinence, apparel, baby, feminine care, air filtration, and food and beverage, for disposable and durable applications. It also provides technical solutions in infrastructure markets. The company's operations are organized into two operating and reportable segments: Americas and Rest of World. It derives the majority of its revenue from the Americas, which manufactures products and components of personal care, including medical garments, wipes, dryer sheets, filtration, baby diapers and adult incontinence.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: